Dr Mark Warne
Appointment to the Board:
Dr Mark Warne was appointed to the hVIVO Board as a Non-Executive Director in April 2016 and is Chairman of the Remuneration Committee.
Experience and expertise
Mark is widely recognised in the UK and International life sciences sector,
currently as a listed company Chief Executive and having spent almost ten years at IP Group Plc, a leading intellectual property commercialisation company, where he led the Healthcare team. He managed a portfolio of £330 million of net assets until 2017 and represented IP Group on the boards of both listed and private companies. Mark joined IP Group from pre-clinical drug discovery CRO, Exelgen, where he was Managing Director. He spent eight years at Exelgen (formerly Tripos Discovery Research) where he also held positions in licensing and strategic affairs, project management and research. Mark has a PhD in Computational Chemistry, an MSc in Colloid Science and a BSc in Chemistry, all from the University of Bristol. Mark is a Chartered Chemist and member of the Royal Society of Chemistry.
Current external appointments
Mark Warne is Chief Executive Officer of DeepMatter Group plc and serves as a non-executive director on the board of Ixico plc.